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Impact of caspase-1/11, -3, -7, or IL-1β/IL-18 deﬁciency
on rabies virus-induced macrophage cell death and
onset of disease
E Kip1,2,3,6, F Nazé1,6, V Suin1, T Vanden Berghe3,4, A Francart1, S Lamoral1, P Vandenabeele3,4, R Beyaert2,3,7, S Van Gucht1,5,7 and
M Kalai1,7,8
Rabies virus is a highly neurovirulent RNA virus, which causes about 59 000 deaths in humans each year. Previously, we described
macrophage cytotoxicity upon infection with rabies virus. Here we examined the type of cell death and the role of speciﬁc caspases
in cell death and disease development upon infection with two laboratory strains of rabies virus: Challenge Virus Standard strain-11
(CVS-11) is highly neurotropic and lethal for mice, while the attenuated Evelyn–Rotnycki–Abelseth (ERA) strain has a broader cell
tropism, is non-lethal and has been used as an oral vaccine for animals. Infection of Mf4/4 macrophages with both strains led to
caspase-1 activation and IL-1β and IL-18 production, as well as activation of caspases-3, -7, -8, and -9. Moreover, absence of caspase-
3, but not of caspase-1 and -11 or -7, partially inhibited virus-induced cell death of bone marrow-derived macrophages. Intranasal
inoculation with CVS-11 of mice deﬁcient for either caspase-1 and -11 or -7 or both IL-1β and IL-18 led to general brain infection
and lethal disease similar to wild-type mice. Deﬁciency of caspase-3, on the other hand, signiﬁcantly delayed the onset of disease,
but did not prevent ﬁnal lethal outcome. Interestingly, deﬁciency of caspase-1/11, the key executioner of pyroptosis, aggravated
disease severity caused by ERA virus, whereas wild-type mice or mice deﬁcient for either caspase-3, -7, or both IL-1β and IL-18
presented the typical mild symptoms associated with ERA virus. In conclusion, rabies virus infection of macrophages induces
caspase-1- and caspase-3-dependent cell death. In vivo caspase-1/11 and caspase-3 differently affect disease development in
response to infection with the attenuated ERA strain or the virulent CVS-11 strain, respectively. Inﬂammatory caspases seem to
control attenuated rabies virus infection, while caspase-3 aggravates virulent rabies virus infection.
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INTRODUCTION
Rabies virus is a negative single-stranded RNA virus belonging to
the Genus Lyssavirus, Familia Rhabdoviridae. It consists of a
helicoidal nucleocapsid, surrounded by a phospholipid mem-
brane, which contains an external glycoprotein (G) and an internal
matrix protein (M).1 Rabies virus is a primary encephalotropic virus,
which causes signiﬁcant mortality worldwide and remains an
important public health problem. Rabies causes about 59 000
human deaths each year.2 Neurons and muscle cells have long
been recognized as the typical target cells of rabies virus, but we
showed that macrophages can also be infected productively and
transmit the virus upon cell transfer in vivo.3 The neurovirulence of
rabies virus is often studied in rodent models using ﬁxed
laboratory strains with different degrees of pathogenicity. The
Challenge Virus Standard strain-11 (CVS-11) is a ﬁxed laboratory
virus that shows a strong neurotropism in mice and causes fatal
acute encephalitis.4,5 Evelyn–Rotnycki–Abelseth virus (ERA) is a
highly attenuated laboratory strain that was adapted to replicate
in non-neuronal cells6 and induces an abortive, non-lethal
infection of the nervous system. ERA triggers an efﬁcient immune
response and has been used as a live vaccine for immunization of
wildlife.7 Preventive therapy for rabies is efﬁcacious, but there is
no effective therapy for patients with symptoms. A better
understanding of basic mechanisms underlying the pathogenesis
of rabies encephalitis, including cell death processes, is needed.8
Programmed cell death is a process by which cells participate in
their own death in a regulated manner. Viral infections often elicit
programmed cell death as part of the host defense system to cut
virus infection and it is not surprising that this is targeted by
pathogen-encoded cell death suppressors to modulate host cell
death pathways.9,10 Apoptosis and pyroptosis constitute major cell
death modes for elimination of infected cells and are character-
ized by distinct signaling pathways and morphologic changes.
Apoptosis is a non-lytic and caspase-dependent host defense
pathway triggered through cell-intrinsic and cell-extrinsic factors.
The extrinsic pathway is based on activation of cell death
receptors, whereas the intrinsic pathway occurs through the
mitochondria. Both pathways lead to activation of effector
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caspases, which ultimately form the apoptosome. There are 13
members of the caspase family. Caspases involved in apoptosis
include caspase-2, -8, -9, -10, and -12 (the initiator caspases) and
caspase-3, -6, -7, and -14 (the effector caspases).9 Rabies virus has
been shown to induce apoptosis and caspase activation in
infected cells,11–13 but the role of apoptosis in pathogenicity is
controversial. Apoptotic neurons were detected in the brain of
mice upon intracranial inoculation of virulent rabies virus.14–16
Jackson et al.17 suggest that there is an inverse relationship
between pathogenicity and neuronal apoptosis and that neuronal
apoptosis does not contribute to pathogenicity in human rabies
encephalitis,18 even if apoptosis is detected in brains of human
patients.19 Others reported that rabies virus can infect mouse and
human lymphocytes and induce their apoptosis20,21 or suggested
that T lymphocytes invading the brain undergo apoptosis, which
may promote the neuroinvasion and spread of virulent rabies
virus.22 A more recent study compared different strains of rabies
virus (virulent street virus CNM11 and attenuated virus CTN) and
detected active caspase-3 in the brain of mice infected with
attenuated or virulent rabies virus.23 A higher rate of apoptosis
was detected in brains of mice infected with the attenuated virus,
with the location of apoptosis depending on the strain. Apoptosis
is thus clearly induced during rabies infection but its exact
contribution in rabies pathogenicity with either attenuated or
virulent rabies virus remains unclear.
Pyroptosis is an inﬂammasome-dependent cell death mode
executed following activation of inﬂammatory caspases caspase-1
or mouse caspase-11. The inﬂammatory caspases in humans
include caspase-1, caspase-4, caspase-5, and caspase-12. In mice,
caspase-11 is the ortholog of human caspase-4 and caspase-5.24
Pyroptosis releases intracellular contents, like necrosis, but also
induces nuclear condensation and DNA fragmentation, like
apoptosis.25 Canonical inﬂammasome activation results in
procaspase-1 cleavage and activation. Distinct inﬂammasomes
can be formed depending on the infectious agent and to date,
ﬁve receptors have been established to form an inﬂammasome
named NLRP1, NLRP3, NLRC4, AIM2, and PYRIN.24,26 Activated-
caspase-1 is responsible for the proteolytic maturation of the
inﬂammatory cytokines pro-IL-1β and pro-IL-18 in myeloid cells
and neurons, which makes pyroptosis a proinﬂammatory cell
death mode. On the other hand, the activation of a noncanonical
inﬂammasome results in activation of procaspase-11. Caspase-11
is required for IL-1β release and pyroptosis in response to Gram-
negative bacteria and cytosolic LPS.27,28 The canonical and
noncanonical inﬂammasomes regulate release of IL-1α and IL-1β
and both caspase-1 and caspase-11 can induce pyroptosis, but
only caspase-1 processes preforms of IL-1β and IL-18 into active
forms, which are secreted.28 Many RNA viruses, such as
encephalomyocarditis virus, vesicular stomatitis virus, measles
virus, hepatitis C virus, and inﬂuenza virus, have been shown
to activate the NLRP3 inﬂammasome.29 Rabies virus was
shown to be recognized by the NLRP3 inﬂammasome and to
activate IL-1β release in murine dendritic cells.29,30 In that study,
IL-1R-deﬁcient mice showed an increase in rabies virus patho-
genicity, but the exact contribution of inﬂammasome-mediated
pyroptosis and IL-1β release in rabies pathogenicity is still
unknown.
It is unclear what is the role of different caspases in rabies virus-
induced cytotoxicity and whether cell death is detrimental, by
contributing to pathogenicity, or beneﬁcial, by limiting virus
spread, for the host.10 In this study, we used speciﬁc caspase-
deﬁcient mice and macrophages to investigate the role of
different caspases and cell death pathways in rabies virus
infection and pathogenesis. First, we examined the type of cell
death and pathways that are activated by rabies virus in an in vitro
cell model. The spleen macrophage-derived Mf4/4 cell line
was initially used because previous studies showed these cells
are highly susceptible for cell death upon infection with rabies
virus. The association between infection, virus production,
and cell viability was examined and compared for two rabies
virus strains with contrasting pathogenic properties, CVS-11
and ERA. Western-blot and immunoprecipitation were applied to
study the activation of apoptotic and pyroptotic pathways in
Mf4/4 macrophages. The impact of caspase-1/11, -3, or -7
deﬁciency on virus-induced cell death was further studied
in bone marrow-derived macrophages (BMDM). Finally, we
examined the impact of a deﬁciency in caspase-1/11, -3, -7, or
IL-1β/IL-18 on the virological and clinical outcome of rabies virus
infection in mice.
RESULTS
ERA and CVS-11 cause cell death and activation of caspases in
Mf4/4 macrophages
We have shown before that rabies virus can infect macrophages
in vitro, but cell death signaling pathways in that type of cell and
their impact on the development of disease were not yet
explored. Here we compared the cytotoxicity of attenuated ERA
and virulent CVS-11 strains toward the cell line Mf4/4. Therefore,
we monitored the production of infectious rabies virus particles
and cell viability up to 48 h post inoculation (hpi) of the cells with
the virus.
Infection of Mf4/4 cells with CVS-11 yielded 103.5 TCID50/ml
infectious particles, which was 10–15-fold less productive than
with the attenuated ERA strain (Figure 1a). The rate of infected
cells was determined using ﬂuorescence microscopy imaging of
cells stained with an antibody directed to the viral N protein
(Figures 1c and d). The majority of the ERA virus-inoculated Mf4/4
cells were infected, since at least 68% expressed the viral N
protein. However, only 9% of the macrophages inoculated with
the CVS-11 were ﬂuorescent for viral N protein (Figures 1c and d).
The percentage of infected cells and production of infectious
rabies virus particles correlated with the rate of cell death, as
assessed by measuring cell adherence. A strong decrease of
macrophage cell adherence was observed upon infection with
ERA (Figure 1b). Only 51% of Mf4/4 remained adherent 48 hpi,
which is signiﬁcantly less than with the virulent strain (88%)
(Po0.001, two-way ANOVA).
In parallel, Mf4/4 cell death induced by rabies virus was
analysed by the binding of the intracellular green ﬂuorescent
caspase inhibitor (FLICA) to active caspases (Figures 1e and f).
Caspase activation was seen in 94,6% of ERA-inoculated cells,
while infection with CVS-11 induced activation of caspases only in
8,8% of the cells, which corresponds with the lower infection rate
of CVS-11 (Figures 1e and f). Mock-infected macrophages showed
no ﬂuorescence in the presence of FLICA. These data suggest that
caspase activation is involved in rabies virus-induced Mf4/4 cell
death and that ERA infects and replicates more efﬁciently in
macrophages than CVS-11. Moreover, both strains induce cell
death,3 but since more macrophages become infected with ERA
than with CVS-11, caspase activation is more obvious with the
former.
Activation of signaling pathways for apoptosis and pyroptosis in
rabies virus-infected Mf4/4
We analysed two forms of cell death requiring caspase activation,
namely apoptosis and pyroptosis, in rabies virus-infected macro-
phages. Since Mf4/4 are highly susceptible to infection with ERA,
we analysed lysates of ERA virus-infected Mf4/4 by western
blotting at 24 and 48 hpi using antibodies against different
caspases and the pro-apoptotic peptide truncated Bid (tBid).
Speciﬁc antibodies against active IL-1β and caspase-1 were used
as pyroptosis markers.
Analysis of cell lysates of ERA virus-infected Mf4/4 indicated that
cleaved active caspase-3, -7, and -9 and tBid were detected 24 hpi,
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whereas proteolytic cleavage of initiator caspase-8 and the 20 kDa
fragment of cleaved and active caspase-1 were detected at 48 hpi
(Figure 2). However, the 15 kDa fragment corresponding to the
active mature form of IL-1β could be immunoprecipitated from
the culture supernatant of infected Mf4/4 already at 24 hpi. The
cleavage of inactive 31 kDa precursor IL-1β to the active mature
cytokine requires active caspase-1, which suggests that caspase-1
was already active at 24 hpi. These observations indicate that
Figure 1. Comparison between viral load and cell death in Mf4/4 cells following infection with ERA or CVS-11 rabies virus strains. (a) Virus titer
was measured at 48 hpi using titration in BHK-21 cells. (b) Cellular viability was determined using the crystal violet staining method to
measure the viable adherent cells as a percentage compared to uninfected control cells. Data are representative of at least ﬁve independent
experiments and are presented as mean values± S.E.M. (c) Fluorescence microscopy imaging of viral N protein to measure the number of
infected Mf4/4. Cells were stained with Hoechst (left panel) and FITC-labeled anti-rabies virus nucleocapsid antibody (right panel). (d) The
percentage of antigen-positive cells is expressed by: (number of FITC-anti-N cells/numbers of Hoechst-positive cells) × 100. (e) Analysis of
caspase activity in infected Mf4/4 cells at 48 h post virus inoculation. Cells were stained with Hoechst (left panel) and with the green
ﬂuorescent caspases inhibitor (FLICA) that covalently binds to the active caspases (right panel). (f) The percentage of cells with active caspases
is expressed by: (number of FLICA-positive cells/number of Hoechst-positive cells) × 100.
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infection of Mf4/4 by ERA involves the proteolytic activation of
several caspases contributing to cell death.
Caspase-3 deﬁciency protects against rabies virus-induced
apoptosis in BMDM
BMDM from wild-type (WT) and deﬁcient mice (caspase-1/11, -3, or
-7 deﬁcient) were used to assess whether the main effectors of
pyroptosis (caspase-1 and -11) and apoptosis (caspase-3 and -7) are
involved in rabies virus-induced cell death. After isolation, cells were
infected with either ERA or CVS-11 and cell adherence was assessed
by crystal violet staining as a measure for cell viability 48 hpi.
Interestingly, a signiﬁcant protective effect on BMDM viability was
observed in caspase-3− /− macrophages infected by ERA or CVS-11
virus (Figures 3a and b). Indeed, an average of 90% viability was
observed in caspase-3− /− BMDM infected with CVS-11 compared to
an average of 66% in WT cells. For ERA virus, an average of 71%
viability was observed in caspase-3− /− BMDM, compared to an
average of 56% in WT cells. In caspase-1/11− /− or caspase-7− /−
BMDM, no signiﬁcant protective effect against cell death was
observed. In parallel, we also examined the effect of caspase-1/11,
-3, or -7 deﬁciencies on rabies virus replication in macrophages. WT
and deﬁcient BMDM were infected with ERA and CVS-11 and the
viral load was determined by RT-qPCR. Results obtained with
caspase-7− /− or caspase-3− /− in comparison to WT BMDM following
48 hpi tended to be highly variable (Figures 3c and d). Nevertheless,
the mean viral load KO/WT ratios obtained with ERA or CVS-11
suggest that caspases-7 may affect rabies virus replication. In
contrast, the variability observed in KO/WT viral load ratios obtained
with caspases-1− /− macrophages after ERA or CVS infection was
low, with means being just below 1.0, suggesting no or low impact
for the caspase on viral replication.
Deﬁciency of caspase-3, but not caspase-1/11, -7, or IL-1β/ IL-18
delays CVS-11-induced disease in mice
The impact of cell death on rabies pathogenicity is controversial.
To better understand the impact of apoptosis and pyroptosis
in vivo during infection with a virulent rabies strain, we studied the
impact of caspase-1/11, -3, or -7 deﬁciency in mice on rabies virus-
induced morbidity and mortality following intranasal inoculation
with CVS-11. Since the production of active IL-1β and IL-18
depends on caspase-1 activity, we also analysed the impact of
IL-1β/IL-18 double deﬁciency in the same experimental set-up.
Neutralizing antibody concentrations in serum and viral load in
the brain were determined at the moment of killing.
WT and deﬁcient mice inoculated with CVS-11 strain developed
severe disease, beginning with weight loss and appearance of a
hunched back, followed by motoric incoordination, a wasp waist
and in the last stage of the disease depression and paralysis of the
hind legs. All mice reached the clinical end point, requiring killing,
about 1–3 days after the appearance of the ﬁrst disease
symptoms. For caspase-3− /− mice, the onset of symptoms was
delayed by 2 days, compared to their corresponding WT mice
(Figure 4b). At 8 DPI, most of the WT, caspase-1/11, -7, and IL1β/
IL-18-deﬁcient mice had reached the maximal clinical score, while
the caspase-3− /− mice were only starting to show the initial
symptoms of the disease (Po0.01). Overall, mortality was 100% in
WT and caspase-deﬁcient mice, but the median survival time was
signiﬁcantly longer for caspase-3− /− mice (Po0.01). This was not
the case for caspase-1, -7, and IL-1β/IL-18-deﬁcient mice. The
median survival time was 8 DPI in WT mice, caspase-1/11, -7, and
IL1β/IL-18-deﬁcient mice and 10–11 DPI in caspase-3− /− mice
(Figure 4a). We have also determined the effect of caspase-1, -3,
-7, or IL1β/IL-18 deﬁciency on the ﬁnal cerebral virus load at the
moment of killing ( = peak of disease), but there was no signiﬁcant
difference (Figure 4c). At the moment of killing (8–11 DPI), none of
Figure 2. Activation of signaling pathways of apoptosis and pyroptosis in rabies virus-infected Mf4/4. Analysis of the proteolytic activation of
caspases-1, -3, -7, -8, and -9, IL-1β and Bid in MF4/4 cells inoculated by ERA. Western blots were performed using antibodies speciﬁc for the
active and inactive forms of these proteins. Upon activation, the protein is cleaved and appears as a smaller band representing the active
protein on the blot. Total cellular lysates were prepared 24 and 48 h after virus inoculation. Uninfected Mf4/4 were prepared in parallel to each
condition as negative controls (CTL). An anti-β-actin antibody was used to verify that equal amounts of protein were loaded. Data are
representative of at least three independent experiments.
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the mice had developed antibody levels above the protective
threshold of 0.5 IU/ml (Figure 4d). In conclusion, these results
indicate that apoptosis through caspase-3 promotes early onset of
disease upon infection with a virulent strain of rabies virus, but has
no effect on ﬁnal viral load in the brain or on ﬁnal disease
outcome.
Deﬁciency of caspase-1/11, but not caspase-3, -7, or IL-1β/ IL-18
increases ERA-induced morbidity in mice
ERA virus is not lethal and induces only minor symptoms in
immunocompetent WT mice. The impact of cell death following
infection with an attenuated rabies strain has been poorly
investigated in vivo. We found that intranasal inoculation of ERA
virus in WT, caspase-3, -7, or IL1β/IL-18− /− mice led to the
development of minor symptoms such as weight loss or motoric
incoordination from 11–18 DPI. In contrast, caspase-1/11− /− mice
developed more severe symptoms, such as hunched back and
paralysis, which lasted for a longer period, with some symptoms
still present at 35 DPI, the end of the observation period. At 20 and
21 DPI, clinical scores were signiﬁcantly higher for caspase-1/11− /−
compared to other mice (Figure 5b). Interestingly, such an ERA-
induced morbidity was not observed with IL-1β/IL-18− /− mice,
suggesting that the impact of caspase-1/11− /− was not due to lack
of these cytokines. No mortality was observed in WT and caspase-
1/11, -3, -7, or IL-1β/IL-18-deﬁcient mice inoculated with ERA.
We next determined if caspase or IL-1β/IL-18 deﬁciency had an
impact on viral load in the brain and neutralizing antibody
production. ERA virus-inoculated mice were killed at 35 DPI. At
that stage, viral RNA was still detectable in the brain, with no
signiﬁcant differences between deﬁcient and WT mice (Figure 5c).
This persistence of ERA virus RNA was not linked to disease, as
most symptoms had disappeared before 35 DPI. All mice
developed a strong antibody response, largely above 0.50 IU/ml,
and there was no signiﬁcant difference in antibody titers
Figure 3. Cellular viability and viral load of caspases-1/11, -3, or -7-deﬁcient primary BMDMs inoculated by CVS-11 (a, c) or ERA (b, d) virus.
(a, b) Cellular viability was determined at 48 hpi using the crystal violet staining method to measure the percentage of viable adherent cells.
P-value was calculated using an unpaired t-test (each group of deﬁcient BMDM compared to the WT group) and was indicated as follows:
P-valueo0.01 (**). A protector effect on the viability of the cells was observed in caspase-3− /− macrophages inoculated with ERA or CVS-11.
Data were pooled and are representative of at least four independent experiments. They are presented as mean values± S.E.M. (c and d) Viral
load was determined 48 hpi by RT-qPCR following CVS-11 or ERA infection. Results are presented as a ratio compared to the WT cells. Each
point represents one independent experiment.
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between WT and deﬁcient mice (Figure 5d). In conclusion, our
results suggest that caspase-1 or caspase-11 controls
attenuated ERA strain infection and disease within the central
nervous system.
DISCUSSION
Apoptosis and pyroptosis can be induced by a wide variety of
stimuli, including viral infection. In this work, we analysed the
impact of key mediators of apoptosis (caspase-3 and -7) and
pyroptosis (caspase-1 and -11) on rabies virus production, cell
death, morbidity, and mortality. Cells of the immune system seem
prone to undergo cell death upon infection with rabies virus.20
This seems particularly the case for the ERA-attenuated strain,
which appears also better ﬁt than CVS-11 to replicate in these
cells. For the in vitro studies, macrophages were used as the
infection model, since these cells are very susceptible to
infection,31–33 especially with the ERA strain, and undergo
distinguishable cell death upon infection. Infection of macro-
phages and their resulting cell death was rabies strain-dependent:
we observed signiﬁcantly higher infection rates, accompanied by
a strong apoptotic response, with the ERA strain than with the
CVS-11 strain. Interestingly, Thoulouze et al.20 reported that in vitro
infection of a human lymphoblastoid Jurkat T-cell line with ERA,
but not with CVS-11, causes apoptosis. They suggested that the
improved capacity of the ERA strain to stimulate the immune
system could be paradoxically linked to its ability to induce
apoptosis in immune system cells. Apoptosis of infected cells may
augment the presentation of viral antigen and then efﬁciently
activate the immune system.
Figure 4. Impact of a deﬁciency in caspase-1/11, -3, or -7 or IL-1β/IL-18 in mice on rabies disease progression, mortality, brain viral load, and
neutralizing antibody response upon infection with a virulent strain of rabies. WT (n= 6), caspase-1/11− /− mice (n= 7), caspase-3− /− mice
(n= 4), caspase-7− /− mice (n= 6), and IL-1β/IL-18− /− mice (n= 3) were inoculated intranasally with the virulent CVS-11 virus (102.5 TCID50/
mouse). Disease progression and mortality within each group was evaluated by mean clinical score per mouse (b) and survival curves (a),
respectively. P-value was calculated using a log-rank test (survival curves) and an ANOVA test followed by Bonferroni multiple comparison
post-test (mean score per mouse) and was indicated as follows: P-value o0.05 (*); P-value o0.01 (**). (a) Survival curves of WT mice and
caspase-3-deﬁcient mice were signiﬁcantly different (**). (b) The mean clinical score per mouse was signiﬁcantly different between WT and
caspase-3− /− mice at 8 DPI. Caspase-3 deﬁciency delayed CVS-11-related disease, but had no effect on ﬁnal lethal outcome. (c) Brain tissue was
sampled upon peak clinical score and viral load measured by RT-qPCR. P-value was calculated with an ANOVA test followed by Bonferroni
multiple comparison post-test. No signiﬁcant difference could be observed between WT mice and deﬁcient mice. (d) The neutralizing
antibody titer was evaluated by rapid ﬂuorescent focus inhibition test and expressed in IU/ml. P-value was calculated by an ANOVA test
followed by Bonferroni multiple comparison post-test. Most mice were unable to mount an antibody response (40.5 IU/ml) prior to killing. No
signiﬁcant difference was observed between WT and deﬁcient mice. Two out of four caspase-3− /− mice had developed antibody titers
40.5 IU/ml, which might be because they survived long enough to allow an antibody response.
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Another study, conducted on the brain of deceased rabies
patients, demonstrated immunostained cleaved caspase-3 in
microglial cells, which are from the macrophage lineage.18 In
our study, we demonstrate that caspases-1/11, -3, -7, -8, and -9,
IL-1β and the Bid factor are activated in Mf4/4 cells upon infection
with ERA. They are also activated after infection with CVS-11, but
to a lesser extent which is probably linked to the lower rate of
infection of Mf4/4 cells. By western blot analysis, we found that
caspase-9 and Bid factor were activated earlier than caspase-8,
suggesting that the apoptotic process is initiated by the activation
of the apoptosome via the mitochondrial pathway and Bid factor
proteolysis.34 The IL-1β activation demonstrates the involvement
of caspase-1 in the inﬂammatory process induced by the ERA
strain in Mf4/4.
Our results on primary BMDM suggest a predominant role of
caspase-3 in cell death induced by ERA and CVS-11 strains in
macrophages, while caspase-1/11 or -7 does not seem to be
necessary. In vivo, apoptotic (cytochrome c, caspase-3) and
pyroptotic (caspase-1, IL-1β) genes were shown to be upregulated
following rabies virus infection.35 In our study, the onset of disease
upon rabies virus infection was signiﬁcantly delayed in caspase-
3− /− mice, compared to WT, IL-1β/IL-18, caspase-1/11, and
caspase-7-deﬁcient mice. This might be explained by an involve-
ment of neuronal apoptosis in the cerebral dysfunction associated
with rabies disease. Indeed, it was shown that CVS-11 produces
neuronal apoptosis in the brain of mice after intracerebral
inoculation, without implication of the adaptive immune system,
as demonstrated in nude and Rag1 mice;36,37 moreover, we
observed immunostaining for cleaved caspase-3 in neuronal cells
of CVS-11-infected mice in our laboratory. In another study,
infection of bax-deﬁcient mice with CVS-11 reduced apoptosis of
neurons from the dentate gyrus and cortical neurons, but still
yielded 100% mortality.38 Moreover, the apoptotic cell death of
neurons is a mechanism known to be implicated in other types of
infectious brain disease, such as reovirus-induced encephalitis.39
Other studies showed no apoptosis in neurons of rabies virus-
infected mice infected intramuscularly by CVS-11, but apoptosis
was detected in microglial cells and T lymphocytes, whereas
Figure 5. Impact of a deﬁciency in caspase-1/11, -3, or -7 or IL-1β/IL-18 in mice on rabies disease progression, mortality, brain viral load, and
neutralizing antibody response upon infection with an attenuated strain of rabies. WT (n= 6), caspase-1/11− /− mice (n= 6), caspase-3− /− mice
(n= 4), caspase-7− /− mice (n= 5), and IL-1β/IL-18− /− mice (n= 4) were inoculated intranasally with the attenuated ERA virus (105 TCID50/
mouse). Disease progression and mortality within each group was evaluated by mean clinical score per mouse (b) and survival curves (a),
respectively. P-value was calculated using a log-rank test (survival curves) and an ANOVA test followed by Bonferroni multiple comparison
post-test (mean score per mouse) and was indicated as follows: P-value o0.05 (*); P-value o0.01 (**). (a) All mice survived the infection
except for one caspase-7− /− mouse. (b) The mean clinical score per mouse was signiﬁcantly different between WT and caspase-1− /−
inoculated with ERA virus at 21 and 20 DPI (c). Brain tissue was sampled at 35 DPI (except for one mouse) and viral load measured by RT-qPCR.
P-value was calculated with an ANOVA test followed by Bonferroni multiple comparison post-test. No signiﬁcant difference could be observed
between WT mice and deﬁcient mice. (d) The neutralizing antibody titer was evaluated by rapid ﬂuorescent focus inhibition test and
expressed in IU/ml. P-value was calculated by an ANOVA test followed by Bonferroni multiple comparison post-test. No signiﬁcant difference
was observed between WT and deﬁcient mice, but antibody titers seemed higher in caspase-3− /− mice.
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neurons died rather by necrosis.40 In another study, apoptosis was
not detected in the brain of experimentally infected mice infected
with a street rabies virus (silver-haired bat rabies virus), although
rabies virus antigens were distributed widely within the CNS.41
The variable results in literature could be related to differences in
virus strain, route of inoculation, or the strain of laboratory animals
used.15,23 Viral loads were similar in all deﬁcient and WT mice,
including caspase-3− /− mice, despite the delay in disease
observed. However, it is important to mention that samples were
only taken at the time of killing, when all mice had developed a
similar level of disease. Analysis of the viral load at comparable
and earlier time points should be performed for more ﬁrm
conclusions.
There is good evidence that pyroptosis can beneﬁt the host
during infection but if too many host cells undergo pyroptosis,
detrimental effects may occur due to the release of inﬂammatory
cytosolic mediators or the depletion of host cells, which highlights
the notion of good versus bad inﬂammation. Previous studies have
shown that increased IL-1β mRNA levels were found in brains of
paralytic rabid dogs during early stages of infection42 and IL-1β
release and Nlrp3 inﬂammasome activation were demonstrated in
murine dendritic cells infected by rabies virus.30 Still, the impact of
pyroptosis in rabies pathogenicity is not well established. We were
not able to prove the involvement of caspase-1 or -11 or IL-1β/
IL-18 on CVS-11-induced morbidity or mortality. On the other
hand, infection of caspase-1/11− /− mice with the ERA strain
showed a worsening of symptoms in comparison to WT mice.
Inﬂammation is thought to promote the viral clearance in rabies
virus infection, especially when the strain is attenuated.43,44 So,
the capacity of caspase-1 to take part in the inﬂammatory process
by cleaving IL-1β could have been a reasonable explanation.
However, in contrast with caspase-1/11− /− mice, inoculation of
IL-1β/IL-18− /− mice with the ERA strain induced no worsening of
symptoms in comparison with WT mice. The higher morbidity
observed in caspase-1/11− /− mice is thus probably not linked to
IL-1β/IL-18 activation and secretion. It is important to note that the
caspase-1/11− /− mice were initially considered as caspase-1− /−,
but the double deﬁciency with caspase-11 was later recognized.28
Thus, the results observed in our study might also involve caspase-
11, which is also implicated in the pyroptosis pathway.
In conclusion, in this study, infection of macrophages was
shown to lead to apoptotic and pyroptotic cell death. In vivo,
apoptosis mediated through caspase-3 seems more detrimental
than protective for the host upon infection with a virulent strain
(CVS-11). Blocking apoptosis with caspase-3 inhibitors might
therefore have beneﬁcial effect on disease. In contrast, during
attenuated rabies strain infection, pyroptosis mediated by
caspase-1 and/or caspase-11 plays a role in limiting the disease
caused by an attenuated rabies virus strain (ERA).
MATERIALS AND METHODS
Virus
The highly virulent neurotropic CVS-11 strain and the attenuated ERA virus,
used as an oral vaccine for immunization of wild life, were obtained from
the American Type Culture Collection (references: VR959 and VR322,
respectively).45 Virus stocks were grown in baby hamster kidney (BHK)-
21 cells. The lysates of infected cell cultures were centrifuged at 20 000× g
for 20 min at 4 °C and the infectious dose was titrated in BHK-21 cells (see
below).
Antibodies and reagents
Crystal violet was purchased from UCB (Brussels, Belgium). FITC-coupled
anti-nucleocapsid rabbit antibody was from Bio-Rad Laboratories (Her-
cules, CA, USA). Horseradish peroxydase (HRP)-linked anti-rat IgG, mouse-
speciﬁc anti-caspase-8, -9, cleaved caspase-7 and -3 polyclonal antibodies
were from BIOKE (Leiden, The Netherlands). Polyclonal anti-mouse IL-1β/
IL-1F2 antibody, monoclonal anti-mouse BID, and monoclonal anti-mouse
IL-1β were from R&D systems (Minneapolis, MN, USA). Mouse-speciﬁc anti-
caspase-1 antibody was made in-house as described before.46 The
anti-rabies virus glycoprotein mouse monoclonal antibody and HRP-
linked anti-goat IgG were from Santa Cruz (Santa Cruz, CA, USA).
HRP-linked anti-mouse and anti-rabbit antibody were from GE Healthcare
(Waukesha, WI, USA). HRP-conjugated anti-β-actin antibody was from ICN
Biomedicals (Irvine, CA, USA).
Cell culture and cellular infection
Mf4/4 is an immortalized cell line of spleen macrophages derived from
C57BL/6 mice.47 BHK-21 are hamster kidney cells that are routinely used to
propagate laboratory strains of rabies virus. Mf4/4 were grown at 37 °C and
5% CO2 in RPMI-1640 (Lonza, Verviers, Belgium) supplemented with 10%
fetal bovine serum, 1 mM sodium pyruvate, 100 U/ml of penicillin, and
100 μg/ml of streptomycin. BHK-21 were grown in DMEM (Gibco, Paisley,
UK) supplemented with 10% fetal bovine serum, 100 U/ml of penicillin,
100 μg/ml of streptomycin, and 0.25 μg/ml of amphotericin B.
BMDMs were isolated from femurs and tibias of 6–12 weeks old C57BL/6
mice. Bone marrow was ﬂushed from the bones with RPMI-1640 and
following centrifugation, cells were suspended in RPMI-1640 supplemen-
ted with 20 ng/ml macrophage-colony stimulating factor (Peprotech,
Rocky Hill, CT, USA) and seeded in a T75 ﬂask. Non-adherent cells were
washed away 4 days later. After 6 days, adherent differentiated
macrophages were collected and reseeded in plates. Macrophage purity
was ~ 98.8% as assessed by ﬂow cytometry using the phycoerythrin-
conjugated monoclonal antibody BM8 anti-F4/80 macrophage marker
(eBioscience, Hartﬁeld, UK).
For cellular infection, Mf4/4 were seeded and infected 24 h later, with
the CVS-11 or ERA strains at a multiplicity of infection of 1. BMDMs were
seeded and infected 2 h later with rabies virus at multiplicity of infection 1
in the presence of macrophage-colony stimulating factor. The cells were
washed 3 h later two times with medium. At the indicated time following
infection, cells were washed and ﬁxed with methanol for 5 min to measure
cell adherence as an indicator for cell viability. Alternatively, cells were
frozen and used for viral titration or collected for RT-qPCR analysis.
Measurement of cell survival
Adherence of Mf4/4 or BMDM was used as a measure for cell survival and
was monitored 48 hpi by crystal violet staining. Adherent cells ﬁxed with
methanol were stained with 0.1% crystal violet for 10 min and washed
twice with PBS. Crystal violet-stained cells were solubilized with a 1%
sodium dodecyl sulfate (SDS) and absorbance at 595 nm was measured
with a spectrophotometer (Model 680 microplate reader, BioRad, Hercules,
CA, USA). Cell survival percentage was calculated using the following
equation: 100%× (A595/655 treated cells—A595/655 medium)/(A595/655
untreated cells—A595/655 medium). Experiments were carried out in
triplicate.
Virus titration
Cells and medium underwent three consecutive freeze-thaw cycles at
− 80 °C. Supernatant and cells were collected and infectious rabies virus
particles were titrated in BHK-21. Results were expressed in 50% tissue
culture infective dose (TCID50)/ml. Virus titration was performed according
to the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals
(Ofﬁce International des Epizooties, 2008).
Anti-nucleocapsid rabies virus staining
Mf4/4 cells were infected with ERA virus or CVS-11 as described above.
At 48 hpi, cells were ﬁxed with 75% acetone for 30 min at room
temperature and incubated with FITC-coupled anti-rabies virus nucleo-
capsid rabbit antibody for 30 min at 37 °C. Next, a DNA Hoechst staining
was performed for 5 min at 37 °C. Cells were washed with distilled water
and the percentage of rabies virus-infected cells was determined using
ﬂuorescence microscopy (Nikon eclipse TS100).
Cellular caspase activation assay
Mf4/4 cells were infected with CVS-11 or ERA virus in 24-well plates. At
48 hpi, cells were incubated with the green ﬂuorescent caspases inhibitor
(FLICA) according to the manufacturer’s instructions (apoptosis detection
kit caspases assay, Eurobio-Abcys, Les Ulis, France). After washing steps,
Pyroptosis and apoptosis in rabies virus infection
E Kip et al
8
Cell Death Discovery (2017) 17012 Ofﬁcial journal of the Cell Death Differentiation Association
the percentage of activated caspase-positive cells was determined using
ﬂuorescence microscopy (Nikon eclipse TS100).
Western blotting and immunoprecipitation
Mf4/4 cells were infected with ERA virus at a multiplicity of infection of 1,
as described above. Mf4/4 cells inoculated with medium were used as a
control. Cells and media were collected at 24 and 48 h post virus
inoculation. Cells were centrifuged at 2500 × g, supernatant was collected
for immunoprecipitation or discarded as indicated. The pellet was
resuspended and boiled for 10 min in sample buffer containing: 6% SDS,
1.4 M β-mercaptoethanol, 20% glycerol, 0.01% (w/v) bromophenol blue,
and 125 mM Tris-HCl, pH 6.8.
For IL-1β immunoprecipitation, collected supernatant media was
supplemented with 10% lysis buffer (50 mM Hepes pH 7.6, 200 mM NaCl,
0.1% de NP40, and 5 mM EDTA), a protease inhibitors tablet (Roche, Basel,
Switzerland) and 2 μg of monoclonal anti-mouse IL-1β. Following 24 h
incubation on a turning wheel at 4 °C, media were incubated with 20 μl
resuspended protein G-sepharose beads (Amersham Bioscience, Freiburg,
Germany) at room temperature under gentle agitation. Following 3 h of
incubation, sepharose beads were washed four times in lysis buffer and
then resuspended and boiled for 5 min in sample buffer. Protein extracts
and immunoprecipitation products were fractionated by SDS-PAGE and
transferred to nitrocellulose membranes. Blocking, antibody incubation
steps, and washing of the membrane were performed in PBS supplemen-
ted with 3% skimmed milk and 0.05% Tween 20. Blots were incubated with
the indicated primary antibody overnight. Membranes were consequently
incubated for 1 h with HRP-conjugated secondary antibodies to mouse,
rabbit, rat, or goat immunoglobulin according to needs. Immunoreactive
proteins were visualized using the chemiluminescence kit ‘Immobilon
Western Chemiluminescent HRP Substrate’ (Millipore, Billerica, MA, USA)
and signals were captured by exposure to ﬁlm (GE Healthcare, Little
Chalfont, UK).
RT-qPCR analysis
RNA extraction was performed using RNeasy Mini kit (Qiagen, Hilden,
Germany) according to the manufacturer’s instructions. Reverse transcrip-
tion and q-PCR were performed as described in Rosseels et al.48 Two
primers (forward and reverse, sequences are accessible on demand;
Eurogentec, Seraing, Belgium) located in the nucleoprotein N genome
region were used for the detection of ERA and CVS-11 strains. The cellular
housekeeping gene, GAPDH, was used for normalization. All samples were
analyzed in duplicates. Ampliﬁcation was performed on an iCycler iQ from
BioRad in a 96-well optical plate format, using the following program:
2 min at 95 °C followed by 45 cycles of 20 s at 95 °C and 30 s at 62 °C. A
melting curve analysis was performed in order to verify the speciﬁcity of
amplicons. Quantiﬁcation of gene expression was performed using the
comparative delta Ct method: delta cycle thresholds (ΔCt) values were
calculated using the following formula: ΔCt = Ctref−Ctsample, with Ctref
equal to 45, which is the number of cycles of this qPCR program.
Mice
All mice were bred under speciﬁc pathogen-free conditions, and in all
experiments sex- and age-matched animals were used. Conditional
caspase-7ﬂ/ﬂ were generated on a mixed 129S6/Swiss background and
back-crossed for 10 generations to the C57BL/6J background before
crossing with Sox2Cre mice to generate caspase-7− /− mice.49 Caspase-
1/11− /−, caspase-3− /−, and IL1β/IL18− /− mice on a C57BL/6J background
were kindly provided by Dr. R Flavell (Howard Hughes Medical Institute,
Chevy Chase, MD, USA), Dr. T Mak (The Campbell Family Cancer Research
Institute, Toronto, Canada), and A Zychlinsky (Max Planck Institute, Berlin,
Germany), respectively. Caspase-1/11− /− mice were initially considered as
caspase-1− /−, but the double deﬁciency with caspase-11 was later
recognized.28 Mice were housed in temperature-controlled, air-
conditioned facilities with 14/10-h light/dark cycles and food and water
ad libitum, and used at the age of 8–12 weeks. All experimental procedures
were approved by the Ethical Committee of the IPH and the Veterinary and
Agrochemical Research Centre (VAR) (advice nr. 060217-03). Mice were
inoculated by intranasal inoculation as described in Rosseels et al.,48 with
102.5 TCID50 of CVS-11 virus or 10
5 TCID50 of ERA virus.
Clinical follow-up and sampling
Mice were observed daily for signs of disease throughout the experiment
until 35 days post inoculation (DPI). Disease signs were scored as follows:
no signs = 0, 420% weight loss = 1, depression= 1, hunched back= 1,
wasp waist = 1, incoordination = 1, and paralysis of hind legs = 1. Mice that
reached a score of 6 were killed by cervical dislocation. A cumulative daily
clinical score per mouse was obtained by adding the scores for each
parameter. Disease progression was represented by a curve of the relative
cumulative score (scores of all mice of a group/number of mice of this
group). Killed mice are included in the curve by adding the score 6 for each
killed mouse. Mice with no apparent rabies disease signs were killed 35
DPI. Blood and brain tissue from each mouse were sampled at the time of
killing for antibody measurement by Rapid Fluorescent Focus Inhibition
Test and viral load determination by RT-qPCR analysis, respectively.
Titration of neutralizing antibody by rapid ﬂuorescent focus
inhibition test
Neutralizing antibodies were titrated with the rapid ﬂuorescent focus
inhibition test according to the Manual of Diagnostic Tests and Vaccines
for Terrestrial Animals (Ofﬁce International des Epizooties, 2008).
Neutralizing antibody titers are expressed as international units (IU)/ml in
reference to ‘The Second International standard for Anti-rabies Immuno-
globulin’, purchased from the United Kingdom National Institute for
Biological Standards and Control. A serum titer of 0.5 IU/ml is considered
protective.
Statistical analysis
Statistical analysis was performed using a student t-test or one-way ANOVA
followed by Bonferroni’s multiple comparison post-test in GraphPad Prism
6. Log-rank test was used to analyse Kaplan–Meier survival curves in
GraphPad Prism 6.
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